99mTc-labeled interleukin-8 for scintigraphic detection of pulmonary infections
H. Rennen, C. Bleeker-Rovers, J. van Eerd, C. Frielink, W. Oyen, F. Corstens and O. BoermanArticles
Chest
2004
1954--1961
Relationship between neutrophil-binding affinity and suitability for infection imaging: comparison of (99m)Tc-labeled NAP-2 (CXCL-7) and 3 C-terminally truncated isoforms
H. Rennen, C. Frielink, E. Brandt, S. Zaat, O. Boerman, W. Oyen and F. CorstensArticles
JNM
2004
1217--1223
Demineralized bone matrix-induced ectopic bone formation in rats: in vivo study with follow-up by magnetic resonance imaging, magnetic resonance angiography, and dual-energy X-ray absorptiometry
E. Hartman, J. Pikkemaat, J. Van Asten, J. Vehof, A. Heerschap, W. Oyen, P. Spauwen and J. JansenArticles
TISENG
2004
747--754
Striatal dopamine and learning strategy-an (123)I-FP-CIT SPECT study
H. Berger, A. Cools, M. Horstink, W. Oyen, E. Verhoeven and S. van der WerfArticles
Neuropsychologia
2004
1071--1078
Radiolabeled compounds in diagnosis of infectious and inflammatory disease
C. Bleeker-Rovers, O. Boerman, H. Rennen, F. Corstens and W. OyenArticles
Curr Pharm Des
2004
2935--2950
Fever of unknown origin: prospective comparison of diagnostic value of (18)F-FDG PET and (111)In-granulocyte scintigraphy
C. Bleeker-Rovers, F. Corstens, J. Der Van Meer and W. OyenArticles
EJNMMI
2004
1342--3; author reply 1344
F-18-fluorodeoxyglucose positron emission tomography leading to a diagnosis of septic thrombophlebitis of the portal vein: description of a case history and review of the literature
C. Bleeker-Rovers, G. Jager, C. Tack, J. Der Van Meer and W. OyenArticles
JIM
2004
419--423
Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation
C. Bleeker-Rovers, E. de Kleijn, F. Corstens, J. van der Meer and W. OyenArticles
EJNMMI
2004
29--37
F-18-fluorodeoxyglucose positron emission tomography for visualization of lipodystrophy in HIV-infected patients
C. Bleeker-Rovers, A. van der Ven, B. Zomer, L. de Geus-Oei, P. Smits, F. Corstens, P. Koopmans and W. OyenArticles
AIDS
2004
2430--2432
Improved tumor targeting of radiolabeled RGD peptides using rapid dose fractionation
M. Janssen, C. Frielink, I. Dijkgraaf, W. Oyen, D. Edwards, S. Liu, M. Rajopadhye, L. Massuger, F. Corstens and O. BoermanArticles
CANBR
2004
399--404
Synthesis and comparison of 99mTc-enrofloxacin and 99mTc-ciprofloxacin
R. Siaens, H. Rennen, O. Boerman, R. Dierckx and G. SlegersArticles
JNM
2004
2088--2094
LRP and PDGF signaling: a pathway to atherosclerosis
P. Boucher and M. GotthardtArticles
TRECVM
2004
55--60
Solitary skull recurrence from stage I seminomatous germ cell tumor of testis
J. Spermon, W. Oyen, S. Strijk, C. de Hulsbergen-van Kaa and J. WitjesArticles
Urology
2004
377--379
Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies
A. Brouwers, P. Mulders, E. Oosterwijk, W. Buijs, F. Corstens, O. Boerman and W. OyenArticles
CANBR
2004
466--477
PET radioimmunoscintigraphy of renal cell cancer using 89Zr-labeled cG250 monoclonal antibody in nude rats
A. Brouwers, I. Verel, J. Van Eerd, G. Visser, M. Steffens, E. Oosterwijk, F. Corstens, W. Oyen, G. Van Dongen and O. BoermanArticles
CANBR
2004
155--163
Targeting of metastatic renal cell carcinoma with the chimeric monoclonal antibody G250 labeled with (131)I or (111)In: an intrapatient comparison
A. Brouwers, W. Buijs, E. Oosterwijk, O. Boerman, C. Mala, P. De Mulder, F. Corstens, P. Mulders and W. OyenArticles
CLINCR
2003
3953S--3960S
Interferons can upregulate the expression of the tumor associated antigen G250-MN/CA IX, a potential target for (radio)immunotherapy of renal cell carcinoma
A. Brouwers, C. Frielink, E. Oosterwijk, W. Oyen, F. Corstens and O. BoermanArticles
CANBR
2003
539--547
Evaluation of Tc-99m-labeled glycoprotein IIb/IIIa receptor antagonist DMP444 SPECT in patients with infective endocarditis
F. Brouwers, W. Oyen, O. Boerman, J. Barrett, F. Verheugt, F. Corstens and J. der Van MeerArticles
CLINNM
2003
480--484